Climacteric. 2004 Mar;7(1):41-9.

Decision-making about hormone replacement therapy by women in England and Scotland.

Authors:

Welton A,Hepworth J,Collins N,Ford D,Knott C,Meredith S,Walgrove A,Wilkes H,Vickers M;

Women's International Study of long Duration Oestrogen after Menopause (WISDOM) team.

Medical Research Council General Practice Research Framework, MRC Clinical Trials Unit, London, England.

Objectives:

The aim of this study was to explore women's decision-making about the balance of risks and benefits of taking hormone replacement therapy (HRT) based on the latest evidence from the Women's Health Initiative (WHI) trial of combined HRT.

Methods:

Women aged 50-69 years, who were eligible for the Women's International Study of long Duration Oestrogen after Menopause (WISDOM) trial, were invited to participate in one of eight focus groups. Participants were asked to discuss their views about taking HRT based on the latest international evidence. RESULTS AND

Conclusions:

Eighty-two women participated overall.Qualitative content analysis was applied to the discussion transcripts. Women regarded the decisions they make about taking HRT as highly personal, and, for women currently taking HRT, the overwhelming reason for continuation was perceived improvement in quality of life regardless of either the risks or the benefits in the longer term.




Please click on the required question.

Women's Health Forum

Thank you for choosing to visit us.

This is the personal website of David A Viniker MD FRCOG, Consultant Obstetrician and Gynaecologist at Whipps Cross University Hospital, London.

I do hope that you find the answers to your questions in the patient information and medical advice provided. If you still have unanswered questions, please consider entering them into one of our forums and I will try to assist you.


 

Women's Health